Cargando…

Generation of a homozygous CIITA knockout iPS cell line using the CRISPR-Cas9 system

Human induced pluripotent stem cells (iPSCs) have great promise in regenerative medicine. However, several limitations, including immune-incompatibility, have raised concerns regarding their clinical application. Recent studies have shown that human iPSCs and their derivatives lose their immunogenic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Romano, Elena, Trionfini, Piera, Giampietro, Roberta, Benigni, Ariela, Tomasoni, Susanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Lab Resource: Genetically-Modified Single Cell Line
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665218/ https://www.ncbi.nlm.nih.gov/pubmed/34688128 http://dx.doi.org/10.1016/j.scr.2021.102580

Ejemplares similares

Generation of two human control iPS cell lines (UCLi016-A and UCLi017-A) from healthy donors with no known ocular conditions
por: Méjécase, Cécile, et al.
Publicado: (2020)

Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson’s disease patients carrying the heterozygous mutations c.1290A > G (p.T351A) or c.2067A > G (p.T610A) in the RHOT1 gene encoding Miro1
por: Chemla, Axel, et al.
Publicado: (2023)

Unravelling the Role of PAX2 Mutation in Human Focal Segmental Glomerulosclerosis
por: Longaretti, Lorena, et al.
Publicado: (2021)

Generation of two isogenic iPS cell lines (IRFMNi002-A and IRFMNi002-B) from a patient affected by Focal Segmental Glomerulosclerosis carrying a heterozygous c.565G>A mutation in PAX2 gene
por: Ciampi, Osele, et al.
Publicado: (2018)

Hypoimmunogenic Human Pluripotent Stem Cells as a Powerful Tool for Liver Regenerative Medicine
por: Trionfini, Piera, et al.
Publicado: (2023)

Long-term adaptive response in COVID-19 vaccine recipients and the effect of a booster dose
por: Perico, Luca, et al.
Publicado: (2023)

Generation of KCL034 clinical grade human embryonic stem cell line
por: Devito, Liani, et al.
Publicado: (2016)

Generation of KCL021 research grade human embryonic stem cell line carrying a ΔF508 mutation in the CFTR gene
por: Miere, Cristian, et al.
Publicado: (2016)

Generation of KCL029 research grade human embryonic stem cell line carrying a mutation in WAS gene
por: Miere, Cristian, et al.
Publicado: (2016)

Generation of KCL031 clinical grade human embryonic stem cell line
por: Jacquet, Laureen, et al.
Publicado: (2016)

Generation of KCL037 clinical grade human embryonic stem cell line
por: Miere, Cristian, et al.
Publicado: (2016)

Generation of KCL039 clinical grade human embryonic stem cell line
por: Devito, Liani, et al.
Publicado: (2016)

Generation of KCL032 clinical grade human embryonic stem cell line
por: Miere, Cristian, et al.
Publicado: (2016)

Generation of KCL016 research grade human embryonic stem cell line carrying a mutation in VHL gene
por: Miere, Cristian, et al.
Publicado: (2016)

Generation of KCL038 clinical grade human embryonic stem cell line
por: Miere, Cristian, et al.
Publicado: (2016)

Generation of KCL040 clinical grade human embryonic stem cell line
por: Jacquet, Laureen, et al.
Publicado: (2016)

Generation of KCL018 research grade human embryonic stem cell line carrying a mutation in the DMPK gene
por: Miere, Cristian, et al.
Publicado: (2016)

Generation of KCL026 research grade human embryonic stem cell line carrying a mutation in SMN1 gene
por: Hewitson, Heema, et al.
Publicado: (2016)

Generation of KCL035 research grade human embryonic stem cell line carrying a mutation in HBB gene
por: Hewitson, Heema, et al.
Publicado: (2016)

Generation of KCL028 research grade human embryonic stem cell line carrying a mutation in the HTT gene
por: Jacquet, Laureen, et al.
Publicado: (2016)

Generation of KCL024 research grade human embryonic stem cell line carrying a mutation in NF1 gene
por: Hewitson, Heema, et al.
Publicado: (2016)

Generation of KCL033 clinical grade human embryonic stem cell line
por: Devito, Liani, et al.
Publicado: (2016)

Generation of KCL025 research grade human embryonic stem cell line carrying a mutation in NF1 gene
por: Hewitson, Heema, et al.
Publicado: (2016)

Generation of KCL017 research grade human embryonic stem cell line carrying a mutation in VHL gene
por: Hewitson, Heema, et al.
Publicado: (2016)

Generation of KCL012 research grade human embryonic stem cell line carrying a mutation in the HTT gene
por: Jacquet, Laureen, et al.
Publicado: (2016)

Generation of KCL013 research grade human embryonic stem cell line carrying a mutation in the HTT gene
por: Jacquet, Laureen, et al.
Publicado: (2016)

Generation of KCL036 research grade human embryonic stem cell line carrying a mutation in the HTT gene
por: Jacquet, Laureen, et al.
Publicado: (2016)

Generation of KCL027 research grade human embryonic stem cell line carrying a mutation in the HTT gene
por: Jacquet, Laureen, et al.
Publicado: (2016)

Generation and characterization of a human iPSC cell line expressing inducible Cas9 in the “safe harbor” AAVS1 locus
por: Castaño, Julio, et al.
Publicado: (2017)

Generation of six induced pluripotent stem cell lines from patients with amyotrophic lateral sclerosis with associated genetic mutations in either FUS or ANXA11
por: Hedges, Erin C., et al.
Publicado: (2021)

Generation of human iPSC line (UCLi013-A) from a patient with microphthalmia and aniridia, carrying a heterozygous missense mutation c.372C>A p.(Asn124Lys) in PAX6
por: Harding, Philippa, et al.
Publicado: (2021)

Generation of WAe001-A-58 human embryonic stem cell line with inducible expression of the SARS-CoV-2 nucleocapsid protein
por: Wu, Feima, et al.
Publicado: (2021)

Generation of two induced pluripotent stem cell (iPSC) lines (BBANTWi006-A, BBANTWi007-A) from Brugada syndrome patients carrying an SCN5A mutation
por: Simons, Eline, et al.
Publicado: (2022)

Generation of four human induced pluripotent stem cell lines from COVID-19 hospitalized patients with increased levels of cardiac Troponin in the acute infection phase developing or not myocarditis
por: Rabino, Martina, et al.
Publicado: (2023)

IPSC reprogramming of two patients with spondyloepimetaphyseal dysplasia (SEMD, biglycan type)
por: De Kinderen, Pauline, et al.
Publicado: (2023)

Two induced pluripotent stem cell (iPSC) lines derived from patients affected by Waardenburg syndrome type 1 retain potential to activate neural crest markers
por: Alkobtawi, Mansour, et al.
Publicado: (2023)

IPSC reprogramming of two patients with spondyloepiphyseal dysplasia congenita (SEDC)
por: De Kinderen, Pauline, et al.
Publicado: (2023)

MicroRNA-184 is a downstream effector of albuminuria driving renal fibrosis in rats with diabetic nephropathy
por: Zanchi, Cristina, et al.
Publicado: (2017)

Editorial: Women in renal pharmacology: 2021
por: Benigni, Ariela, et al.
Publicado: (2022)

Homozygous might be hemizygous: CRISPR/Cas9 editing in iPSCs results in detrimental on-target defects that escape standard quality controls
por: Simkin, Dina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gf2ohmi0pl8hmk9vfmk6jqcge8